Ocular Therapeutix (OCUL) Insider Trading & Ownership → Must-See: Elon’s New Invention is Absolutely Insane (From InvestorPlace) (Ad) Free OCUL Stock Alerts $5.93 +0.13 (+2.24%) (As of 05/28/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Ocular Therapeutix (NASDAQ:OCUL) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.50%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$7.02 MNumber OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$198,963.46 Get OCUL Insider Trade Alerts Want to know when executives and insiders are buying or selling Ocular Therapeutix stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address OCUL Insider Buying and Selling by Quarter Ad Chaikin AnalyticsWall Street Legend Warns: "A Strange Day Is Coming to America"Get Your Cash Out of U.S. Banks Immediately Man who predicted 2023 bank run warns a historic financial reset is coming. Get out of cash and into a new vehicle 50 years in the making.Click here to learn more. Ocular Therapeutix Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails2/26/2024Summer Road LlcMajor ShareholderBuy930,851$7.52$6,999,999.52 1/31/2024Antony C MattessichCEOSell18,338$4.95$90,773.10 1/31/2024Donald NotmanCFOSell6,433$4.95$31,843.35 1/31/2024Philip C StrassburgerGeneral CounselSell6,831$4.95$33,813.45 1/31/2024Rabia Gurses OzdenInsiderSell7,764$4.95$38,431.80 8/30/2023Antony C MattessichCEOBuy6,500$3.81$24,765.00 7/7/2023Rabia Gurses OzdenInsiderSell832$4.93$4,101.76 (Data available from 1/1/2013 forward) OCUL Insider Trading Activity - Frequently Asked Questions Who is on Ocular Therapeutix's Insider Roster? The list of insiders at Ocular Therapeutix includes Antony C Mattessich, Christopher G White, Donald Notman, Philip C Strassburger, Rabia Gurses Ozden, and Summer Road Llc. Learn more on insiders at OCUL. What percentage of Ocular Therapeutix stock is owned by insiders? 5.50% of Ocular Therapeutix stock is owned by insiders. Learn more on OCUL's insider holdings. Which Ocular Therapeutix insiders have been buying company stock? The following insiders have purchased OCUL shares in the last 24 months: Antony C Mattessich ($24,765.00), and Summer Road Llc ($7,749,999.52). How much insider buying is happening at Ocular Therapeutix? Insiders have purchased a total of 1,103,479 OCUL shares in the last 24 months for a total of $7,774,764.52 bought. Which Ocular Therapeutix insiders have been selling company stock? The following insiders have sold OCUL shares in the last 24 months: Antony C Mattessich ($174,169.66), Christopher G White ($24,714.96), Donald Notman ($59,301.59), Philip C Strassburger ($60,020.89), and Rabia Gurses Ozden ($42,533.56). How much insider selling is happening at Ocular Therapeutix? Insiders have sold a total of 78,353 Ocular Therapeutix shares in the last 24 months for a total of $360,740.66 sold. More Insider Trading Tools from MarketBeat Related Companies: INVA Insider Trading PLRX Insider Trading ARQT Insider Trading PHAT Insider Trading KNSA Insider Trading TBPH Insider Trading SUPN Insider Trading KPTI Insider Trading AXSM Insider Trading MRUS Insider Trading Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Stocks Insiders are Buying That Should be on Your RadarInsider Trading is Good News for These Stocks4 Small-Cap Energy Stocks Insiders are Buying 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month This page (NASDAQ:OCUL) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy SykesElon’s New Device is About to Shock the WorldInvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for AIWeiss RatingsThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaDigitizing the $11T commodities sector with one tiny stockResource Stock DigestMusk, Bezos, and Gates All On Board… Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ocular Therapeutix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.